Close Menu

NEW YORK (GenomeWeb) – Biocept announced today that it has signed an agreement under which its Target Selector liquid biopsy tests and services will be marketed to community-based oncologists and hematologists in the US by Miraca Life Sciences (MLS).

Under the terms of the promotion and marketing deal, Texas-based MLS will promote Target Selector testing to its new and existing clinician clients in certain unnamed sales territories in the US. Biocept will perform the tests at its CLIA lab in San Diego.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.